Visunex Medical Systems raised $20 million in a Series B round, which will expand its R&D and manufacturing operations. The company markets a wireless digital imaging system that screens for eye disorders in newborns.
The Fremont, California-based company markets the PanoCam suite of devices, wide-field digital imaging tools for newborns and infants.
The PanoCam LT system comprises an image-capturing device, review software and a color printer, which fit into a suitcase for easy transport. Images and data are transmitted wirelessly between the components and to the cloud.
Related: Gobiquity picks up Series B to advance smartphone amblyopia screening app
Its followup, the PanoCam Pro, scored FDA clearance last year, and Visunex plans to launch another device later this year, according to a statement.
"This new round of funding brings the total investment into Visunex Medical to $32 million, and will allow the company to expand manufacturing operations to meet the market demand,” said Visunex CEO Wei Su in the statement. “We will also increase our investment in R&D, including resources, to bring additional products and clinical options through the development pipeline and into the market.”